Mediation analysis of time‐to‐event endpoints accounting for repeatedly measured mediators subject to time‐varying confounding

In this article, we will present statistical methods to assess to what extent the effect of a randomised treatment (versus control) on a time‐to‐event endpoint might be explained by the effect of treatment on a mediator of interest, a variable that is measured longitudinally at planned visits throughout the trial. In particular, we will show how to identify and infer the path‐specific effect of treatment on the event time via the repeatedly measured mediator levels. The considered proposal addresses complications due to patients dying before the mediator is assessed, due to the mediator being repeatedly measured, and due to posttreatment confounding of the effect of the mediator by other mediators. We illustrate the method by an application to data from the LEADER cardiovascular outcomes trial.

[1]  Chen Avin,et al.  Identifiability of Path-Specific Effects , 2005, IJCAI.

[2]  S. Seaman,et al.  Methods for handling longitudinal outcome processes truncated by dropout and death , 2017, Biostatistics.

[3]  J. Robins,et al.  Alternative Graphical Causal Models and the Identification of Direct E!ects , 2010 .

[4]  Stijn Vansteelandt,et al.  Interventional Effects for Mediation Analysis with Multiple Mediators. , 2017, Epidemiology.

[5]  Judea Pearl,et al.  Direct and Indirect Effects , 2001, UAI.

[6]  T J VanderWeele,et al.  Mediation Analysis with Multiple Mediators , 2014, Epidemiologic methods.

[7]  O. Aalen.  A linear regression model for the analysis of life times. , 1989, Statistics in medicine.

[8]  P. Shrout,et al.  Causality and Psychopathology: Finding the Determinants of Disorders and their Cures , 2010 .

[9]  P. Royston,et al.  Flexible parametric proportional‐hazards and proportional‐odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects , 2002, Statistics in medicine.

[10]  T. VanderWeele,et al.  Mediation analysis with time varying exposures and mediators , 2017, Journal of the Royal Statistical Society. Series B, Statistical methodology.

[11]  Wenjing Zheng,et al.  Longitudinal Mediation Analysis with Time-varying Mediators and Exposures, with Application to Survival Outcomes , 2017, Journal of causal inference.

[12]  Tyler J VanderWeele,et al.  Mediation analysis for a survival outcome with time‐varying exposures, mediators, and confounders , 2017, Statistics in medicine.

[13]  I. Shpitser,et al.  CAUSAL INFERENCE WITH A GRAPHICAL HIERARCHY OF INTERVENTIONS. , 2014, Annals of statistics.

[14]  John B Buse,et al.  Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes. , 2016, The New England journal of medicine.

[15]  Vanessa Didelez,et al.  Defining causal meditation with a longitudinal mediator and a survival outcome , 2018, Lifetime data analysis.

[16]  C. Blanco,et al.  Causality and Psychopathology: Finding the Determinants of Disorders and Their Cures , 2011 .

[17]  David A. McAllester,et al.  Proceedings of the Twenty-Fifth Conference on Uncertainty in Artificial Intelligence , 2009, UAI 2009.

[18]  J. Robins,et al.  Identifiability and Exchangeability for Direct and Indirect Effects , 1992, Epidemiology.

[19]  J. Pearl.  Causality: Models, Reasoning and Inference , 2000 .

[20]  O. Aalen,et al.  Dynamic path analysis—a new approach to analyzing time-dependent covariates , 2006, Lifetime data analysis.

[21]  D. Mackinnon.  Introduction to Statistical Mediation Analysis , 2008 .

[22]  Ilya Shpitser,et al.  Counterfactual Graphical Models for Longitudinal Mediation Analysis With Unobserved Confounding , 2012, Cogn. Sci..

[23]  H Putter,et al.  Tutorial in biostatistics: competing risks and multi‐state models , 2007, Statistics in medicine.

[24]  S. Vansteelandt,et al.  Flexible Mediation Analysis With Multiple Mediators. , 2017, American journal of epidemiology.

[25]  Jin Tian,et al.  A general identification condition for causal effects , 2002, AAAI/IAAI.

[26]  James M. Robins,et al.  Effect decomposition in the presence of an exposure-induced mediator-outcome confounder. , 2014, Epidemiology.

[27]  B. Zinman,et al.  Cardiovascular Risk Reduction With Liraglutide: An Exploratory Mediation Analysis of the LEADER Trial , 2020, Diabetes Care.

[28]  S Vandenberghe,et al.  Boosting the precision of mediation analyses of randomised experiments through covariate adjustment. , 2017, Statistics in medicine.

[29]  J. Robins,et al.  Marginal Structural Models and Causal Inference in Epidemiology , 2000, Epidemiology.

[30]  Ørnulf Borgan,et al.  Dynamic path analysis – a useful tool to investigate mediation processes in clinical survival trials , 2015, Statistics in medicine.

[31]  Thomas S. Richardson,et al.  A factorization criterion for acyclic directed mixed graphs , 2009, UAI.